Table 1 Incidence of discontinuation and adverse events
3-MU group, No. (%) | 6-MU group, No. (%) | P value | |
|---|---|---|---|
Patient number | 80 | 134 | |
Discontinuation | 4 (5.0) | 10 (7.5) | NS |
Adverse event | 3 (3.8) | 6 (4.5) | NS |
Insufficient response | 1 (1.3) | 1 (0.7) | NS |
Laboratory abnormality | 0 (0) | 1 (0.7) | NS |
Economic problem | 0 (0) | 2 (1.5) | NS |
Adverse event | |||
Flu-like symptoms† | 49 (61.3) | 85 (63.4) | NS |
Gastrointestinal manifestations‡ | 19 (23.8) | 35 (26.1) | NS |
Psychological manifestations§ | 34 (41.0) | 74 (55.2) | 0.028 |
Alopecia | 13 (16.3) | 30 (22.4) | NS |
Dermatological manifestations¶ | 11 (13.8) | 19 (14.2) | NS |